According to top government officials, the government expects four additional vaccinations to join its arsenal by October, and it expects…
Drug firm Zydus Cadila on Friday said it has received final approval from the US health regulator to market Fulvestrant…
Ahmedabad-based Zydus Cadila, which has created India's second home-made coronavirus vaccine (Covid-19), has reportedly submitted more data related to the…
According to a 48-person phase I study published ahead of print in the Lancet's EClinicalMedicine journal, the DNA vaccine produced…
New Delhi: Drug firm Zydus Cadila on Wednesday said it has received tentative approval from the US health regulator to market Ibrutinib tablets used…
The drug regulatory body of India will consider emergency use approval for Zydus Cadila’s Covid-19 vaccine this week and the…
Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market generic Emtricitabine and Tenofovir…
Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market generic Emtricitabine…
Zydus Cadila has approached India’s top drug regulator for restricted emergency approval of ZyCov-D, its three-dose Covid-19 vaccine. If granted, this would…
Zydus Cadila, the Ahmedabad-based vaccine maker, is likely to apply for emergency use authorisation to the Drug Controller General of…